What it sells
AI drug discovery / AI scientist agent for bio research
Business model breakdown
Buyer: who owns the budget?
UnverifiedResearch directors and PIs at universities, institutes, hospitals and bio companies.
Trigger: what makes them buy now?
Slow manual bio data analysis and literature review; claims 2 hours to analyze a year's papers in press.
Workflow: what inputs become what output?
Nexus Co-Scientist: nine AI agents (leadership, literature, omics, cell biology, drug discovery, bioinformatics, domain expert, support, publication) collaborate on a research project from design to analysis and paper drafting; Agentic-RAG for retrieval.
Economics: what it saves and how it charges
UnverifiedProject/platform services for research customers; site claims 50+ projects, PB-scale data and large analysis time savings (figures are counters).
Distribution: how it reaches customers
Direct, partnership with research institutions, inquiry form.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-08-07 | Seed | — | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.